Most read this year

Evidence suggests immunity following infection should generally last six months in healthy adults and can be prolonged with vaccination – but there are exceptions.
Jessica Khachan shares her experiences with codeine addiction.
In 2026, almost 19,000 influenza cases have been reported across Australia.
The PBAC has released its recommendation on which groups should be prioritised to ensure ‘equitable subsidised access to GLP-1 for the treatment of obesity’.
The SELECT trial found that Wegovy can reduce cardiovascular events by 20% in people with pre-existing heart disease who were overweight or obese but did not have diabetes.
The education letters have been sent to the top 10 % of prescribers whose patients have no prior history of T2DM.
Despite being developed in Victoria, the guidelines are suitable for GPs to use across Australia when advising patients on driving and medicinal cannabis.
GPs are warning of unapproved peptide products such as retatrutide posing ‘significant’ health risks.
The newly updated guidelines include changes to drug recommendations for common infections widely seen in general practice.
PMOS affects around one in eight women worldwide.